Butterfield, D. ., Di Domenico, F. ., Swomley, A. ., Head, E. ., & Perluigi, M. . (2014). Redox proteomics analysis to decipher the neurobiology of Alzheimer-like neurodegeneration: overlaps in Down’s syndrome and Alzheimer’s disease brain. The Biochemical Journal, 463(2), 177-89. https://doi.org/10.1042/BJ20140772 (Original work published 2014)

Butterfield, D. ., Di Domenico, F. ., & Barone, E. . (2014). Elevated risk of type 2 diabetes for development of Alzheimer disease: a key role for oxidative stress in brain. Biochimica Et Biophysica Acta, 1842(9), 1693-706. https://doi.org/10.1016/j.bbadis.2014.06.010

Butterfield, D. ., Gu, L. ., Di Domenico, F. ., & Robinson, R. . (1969). Mass spectrometry and redox proteomics: applications in disease. Mass Spectrometry Reviews, 33(4), 277-301. https://doi.org/10.1002/mas.21374 (Original work published 1969)

Perluigi, M. ., Pupo, G. ., Tramutola, A. ., Cini, C. ., Coccia, R. ., Barone, E. ., … Di Domenico, F. . (2014). Neuropathological role of PI3K/Akt/mTOR axis in Down syndrome brain. Biochimica Et Biophysica Acta, 1842(7), 1144-53. https://doi.org/10.1016/j.bbadis.2014.04.007

Di Domenico, F. ., Pupo, G. ., Tramutola, A. ., Giorgi, A. ., Schininà, M. ., Coccia, R. ., … Perluigi, M. . (2014). Redox proteomics analysis of HNE-modified proteins in Down syndrome brain: clues for understanding the development of Alzheimer disease. Free Radical Biology & Medicine, 71, 270-280. https://doi.org/10.1016/j.freeradbiomed.2014.03.027

Barone, E. ., Di Domenico, F. ., & Butterfield, D. . (2014). Statins more than cholesterol lowering agents in Alzheimer disease: their pleiotropic functions as potential therapeutic targets. Biochemical Pharmacology, 88(4), 605-16. https://doi.org/10.1016/j.bcp.2013.10.030 (Original work published 2014)